Literature DB >> 27900034

miR-520e regulates cell proliferation, apoptosis and migration in breast cancer.

Ming Yi1, Minghua Li2, Xia Long2, Jing Ye2, Junwei Cui2, Wei Wei2, Huijuan Wan2, Meijun Yin2, Shuying Gao3, Zhengming Su1, Fangting Zhang2.   

Abstract

Previous studies have indicated that the deregulation of microRNAs contributes to tumorigenesis. Misregulation of microRNA-520e (miR-520e) has been observed in various types of cancer. However, the expression profile and biological function of miR-520e in breast cancer remains largely unknown. The present study demonstrated that miR-520e expression was significantly increased in breast cancer tissues compared with adjacent non-cancerous breast tissues in 21 patients, as revealed by reverse transcription-quantitative polymerase chain reaction. Furthermore, the proliferation capacity of breast cancer cells was markedly enhanced by the introduction of miR-520e in vitro using a cell counting kit-8 assay. The present study also revealed that the overexpression of miR-520e could suppress breast cancer cell apoptosis, revealed using Annexin V/propidium iodide double staining and flow cytometry analysis. In addition, the ectopic expression of miR-520e promoted the migration of breast cancer cells in vitro, as demonstrated by a Transwell assay. Overall, the findings of the present study highlight an important role for miR-520e in breast cancer development and in the molecular etiology of breast cancer, which indicates the potential application of miR-520e in cancer therapy.

Entities:  

Keywords:  apoptosis; breast cancer; miRNA-520e; migration; proliferation

Year:  2016        PMID: 27900034      PMCID: PMC5103980          DOI: 10.3892/ol.2016.5085

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  32 in total

1.  Breast cancer.

Authors:  Michelle Grayson
Journal:  Nature       Date:  2012-05-30       Impact factor: 49.962

2.  Genomic and transcriptional aberrations linked to breast cancer pathophysiologies.

Authors:  Koei Chin; Sandy DeVries; Jane Fridlyand; Paul T Spellman; Ritu Roydasgupta; Wen-Lin Kuo; Anna Lapuk; Richard M Neve; Zuwei Qian; Tom Ryder; Fanqing Chen; Heidi Feiler; Taku Tokuyasu; Chris Kingsley; Shanaz Dairkee; Zhenhang Meng; Karen Chew; Daniel Pinkel; Ajay Jain; Britt Marie Ljung; Laura Esserman; Donna G Albertson; Frederic M Waldman; Joe W Gray
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

3.  MicroRNAs modulate hematopoietic lineage differentiation.

Authors:  Chang-Zheng Chen; Ling Li; Harvey F Lodish; David P Bartel
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

4.  Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers.

Authors:  George Adrian Calin; Cinzia Sevignani; Calin Dan Dumitru; Terry Hyslop; Evan Noch; Sai Yendamuri; Masayoshi Shimizu; Sashi Rattan; Florencia Bullrich; Massimo Negrini; Carlo M Croce
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-18       Impact factor: 11.205

Review 5.  Genetic and epigenetic aspects of breast cancer progression and therapy.

Authors:  Shannon Byler; Sarah Goldgar; Sarah Heerboth; Meghan Leary; Genevieve Housman; Kimberly Moulton; Sibaji Sarkar
Journal:  Anticancer Res       Date:  2014-03       Impact factor: 2.480

6.  MicroRNA-205 signaling regulates mammary stem cell fate and tumorigenesis.

Authors:  Chi-Hong Chao; Chao-Ching Chang; Meng-Ju Wu; How-Wen Ko; Da Wang; Mien-Chie Hung; Jer-Yen Yang; Chun-Ju Chang
Journal:  J Clin Invest       Date:  2014-06-09       Impact factor: 14.808

Review 7.  Role of miR-10b in breast cancer metastasis.

Authors:  Li Ma
Journal:  Breast Cancer Res       Date:  2010-10-26       Impact factor: 6.466

8.  A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells.

Authors:  Ulrike Burk; Jörg Schubert; Ulrich Wellner; Otto Schmalhofer; Elizabeth Vincan; Simone Spaderna; Thomas Brabletz
Journal:  EMBO Rep       Date:  2008-05-16       Impact factor: 8.807

9.  miR-125b acts as a tumor suppressor in breast tumorigenesis via its novel direct targets ENPEP, CK2-α, CCNJ, and MEGF9.

Authors:  Andrea Feliciano; Josep Castellvi; Ana Artero-Castro; Jose A Leal; Cleofé Romagosa; Javier Hernández-Losa; Vicente Peg; Angels Fabra; Francisco Vidal; Hiroshi Kondoh; Santiago Ramón Y Cajal; Matilde E Lleonart
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

Review 10.  Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives.

Authors:  Antonio Díaz-López; Gema Moreno-Bueno; Amparo Cano
Journal:  Cancer Manag Res       Date:  2014-04-25       Impact factor: 3.989

View more
  2 in total

1.  CyclinD1 Is a New Target Gene of Tumor Suppressor MiR-520e in Breast Cancer.

Authors:  Quan Liang; Qingjuan Yao; GuoYing Hu
Journal:  Open Med (Wars)       Date:  2019-12-04

2.  miRNA expression profiling in formalin-fixed paraffin-embedded endometriosis and ovarian cancer samples.

Authors:  Ovidiu-Leonard Braicu; Liviuta Budisan; Rares Buiga; Ancuta Jurj; Patriciu Achimas-Cadariu; Laura Ancuta Pop; Cornelia Braicu; Alexandru Irimie; Ioana Berindan-Neagoe
Journal:  Onco Targets Ther       Date:  2017-08-28       Impact factor: 4.147

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.